α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophy.
α-Synuclein in blood exosomes immunoprecipitated using neuronal and oligodendroglial markers distinguishes Parkinson's disease from multiple system atrophy.
复制标题
用神经元和少突胶质细胞标记物免疫共沉淀的血中α-突触核蛋白可区分帕金森氏病和多系统萎缩。
DOI:
10.1007/s00401-021-02324-0
复制
发表时间:
2021-09
影响因子:
12.7
通讯作者:
Bitan G
中科院分区:
文献类型:
--
作者:
Dutta S;Hornung S;Kruayatidee A;Maina KN;Del Rosario I;Paul KC;Wong DY;Duarte Folle A;Markovic D;Palma JA;Serrano GE;Adler CH;Perlman SL;Poon WW;Kang UJ;Alcalay RN;Sklerov M;Gylys KH;Kaufmann H;Fogel BL;Bronstein JM;Ritz B;Bitan G
The diagnosis of Parkinson’s disease (PD) and atypical parkinsonian syndromes is difficult due to the lack of reliable, easily accessible biomarkers. Multiple system atrophy (MSA) is a synucleinopathy whose symptoms often overlap with PD. Exosomes isolated from blood by immunoprecipitation using CNS markers provide a window into the brain’s biochemistry and may assist in distinguishing between PD and MSA. Thus, we asked whether α-synuclein (α-syn) in such exosomes could distinguish among healthy individuals, patients with PD, and patients with MSA. We isolated exosomes from the serum or plasma of these three groups by immunoprecipitation using neuronal and oligodendroglial markers in two independent cohorts and measured α-syn in these exosomes using an electrochemiluminescence ELISA. In both cohorts, α-syn concentrations were significantly lower in the control group and significantly higher in the MSA group compared to the PD group. The ratio between α-syn concentrations in putative oligodendroglial exosomes compared to putative neuronal exosomes was a particularly sensitive biomarker for distinguishing between PD and MSA. Combining this ratio with the α-syn concentration itself and the total exosome concentration, a multinomial logistic model trained on the discovery cohort separated PD from MSA with an AUC = 0.902, corresponding to 89.8% sensitivity and 86.0% specificity when applied to the independent validation cohort. The data demonstrate that a minimally invasive blood test measuring α-syn in blood exosomes immunoprecipitated using CNS markers can distinguish between patients with PD and patients with MSA with high sensitivity and specificity. Future optimization and validation of the data by other groups would allow this strategy to become a viable diagnostic test for synucleinopathies.
登录
查看更多内容
影响因子:
15.1
作者:
Danzer KM;Kranich LR;Ruf WP;Cagsal-Getkin O;Winslow AR;Zhu L;Vanderburg CR;McLean PJ
通讯作者:
McLean PJ
影响因子:
9.9
作者:
Goetzl, Edward J.;Boxer, Adam;Kapogiannis, Dimitrios
通讯作者:
Kapogiannis, Dimitrios
影响因子:
5.3
作者:
Emmanouilidou, Evangelia;Melachroinou, Katerina;Vekrellis, Kostas
通讯作者:
Vekrellis, Kostas
影响因子:
14.5
作者:
Alcalay, Roy N.;Levy, Oren A.;Zhang, Xiaokui
通讯作者:
Zhang, Xiaokui
影响因子:
4.6
作者:
Foulds PG;Diggle P;Mitchell JD;Parker A;Hasegawa M;Masuda-Suzukake M;Mann DM;Allsop D
通讯作者:
Allsop D